+196.4%
DOCN vs THC
+418.9%
-222.5%
-61.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -15.9% | -2.0% | -13.9% | -15.7% |
| 7D | -29.3% | +5.9% | -35.2% | -29.7% |
| 30D | -46.0% | +10.8% | -56.9% | -46.6% |
| 3M | -43.2% | +9.4% | -52.6% | -43.8% |
| 6M | -53.7% | +53.3% | -107.0% | -56.7% |
| YTD | +46.9% | +44.2% | +2.8% | +37.3% |
| 1Y | +54.3% | +37.3% | +17.0% | +45.7% |
| All | +196.4% | +418.9% | -222.5% | +41.4% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling